CPAP Adherence Rose Among GLP-1 Patients
Data shows that patients using weight-loss drugs are more likely to stick with sleep apnea therapy.
Updated on Sept. 22, 2026 in Weight Loss
Live Poll
Do you trust that weight-loss medications improve your overall adherence to other health therapies?
ResMed reported that patients prescribed GLP-1 weight-loss medications demonstrated higher rates of CPAP therapy adherence. The findings suggest that those pursuing weight loss may be more engaged with their long-term health outcomes.
Why it matters
The intersection of GLP-1 usage and respiratory health management could improve outcomes for sleep apnea sufferers. Weight loss facilitated by these medications may enhance device comfort, leading to more consistent use and better overall treatment success.
A study of 2.5 million de-identified patients showed the combination group saw resupply rates 300 basis points higher at one year and 600 basis points higher at three years compared to controls.
The players
ResMed
This is a global medical device company that specializes in cloud-connected solutions for treating sleep apnea and other respiratory conditions.
Mick Farrell
He serves as the Chief Executive Officer of ResMed and is responsible for the company's long-term strategic direction.
The details
ResMed used its cloud-connected systems to track therapy usage across a massive cohort of patients concurrently using CPAP devices and GLP-1 prescriptions. The data suggests that as users lose weight, the reduced pressure requirements for their CPAP machines may make the equipment easier to use, further incentivizing compliance.
Timeline
September 2026: CEO Mick Farrell presented the findings at a conference.
The Big Picture
The study aligns with the broader deployment of the ResMed cloud-connected patient monitoring system to track long-term health outcomes. It underscores the evolving convergence between weight-loss pharmacotherapy and legacy respiratory care devices.
Patients who use both CPAP therapy and GLP-1 medications may find that they are more consistent with their health routines and device usage. This correlation suggests that medical providers could see better treatment adherence when coordinating both weight management and respiratory care.
The takeaway
Patients managing weight loss alongside sleep apnea should discuss the potential for device adjustment with their medical team. Consistent therapy usage remains the most critical factor in mitigating the long-term health risks associated with untreated sleep apnea.
Further reading
Learn more about the latest innovations in Weight Loss treatments and their broader health impacts.
Source note: This article includes information reported by MDDI Online.
Live Poll
Do you trust that weight-loss medications improve your overall adherence to other health therapies?
